Abiopharma

🔍 Guerrero Paula L (Executive)

Company: CITIZENS, INC. (CIA)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 2,197 shares of Citizens, Inc. Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,874.98 | transaction_form_type: 4 | Footnotes: F1
• Sold 767 shares of Citizens, Inc. Class A Common Stock at $5.03 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 16,107.98 | transaction_form_type: 4
• Acquired 1,923 shares of Citizens, Inc. Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,030.98 | transaction_form_type: 4 | Footnotes: F2
• Sold 672 shares of Citizens, Inc. Class A Common Stock at $5.03 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 17,358.98 | transaction_form_type: 4
• Sold 2,197 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,396.00 | transaction_form_type: 4 | Footnotes: F3, F1, F1
• Sold 1,923 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,846.00 | transaction_form_type: 4 | Footnotes: F3, F2, F2
• Acquired 5,964 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,964.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4
• Holds 2,709 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 2,709.00 | Footnotes: F3, F5, F5
• Holds 3,035 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 3,035.00 | Footnotes: F3, F6, F6

Footnotes:

• F1: On March 31, 2025, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2025 long-term incentive. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2026) an dthe second anniversary of the date of the grant (March 31, 2027) and the third anniversary of the date of the grant (March 31, 2028).
• F2: On March 31, 2025, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2024 pay-for-performance. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2026) an dthe second anniversary of the date of the grant (March 31, 2027) and the third anniversary of the date of the grant (March 31, 2028).
• F3: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock.
• F4: On March 31, 2026, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2026 long-term incentive. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2027) an dthe second anniversary of the date of the grant (March 31, 2028) and the third anniversary of the date of the grant (March 31, 2029).
• F5: Initial grant was issued on August 15, 2023 and remaining number of shares will vest 1/2 on August 14, 2025 and 1/2 on August 15, 2026.
• F6: Vesting is 1/3 on the first anniversary of the date of the grant (March 28, 2025), 1/3 on the second anniversary of the grant (March 28, 2026) and 1/3 on the third anniversary of the grant (March 28, 2027).